Neonatal jaundice ultrasound: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neonatal jaundice}} | {{Neonatal jaundice}} | ||
{{CMG}} {{AE}} | {{CMG}}; {{AE}} {{AEL}} | ||
==Overview== | ==Overview== |
Revision as of 17:00, 30 January 2018
Neonatal jaundice Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neonatal jaundice ultrasound On the Web |
American Roentgen Ray Society Images of Neonatal jaundice ultrasound |
Risk calculators and risk factors for Neonatal jaundice ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Ultrasonography of the liver and bile ducts is warranted in infants with laboratory or clinical signs of cholestatic disease.
Ultrasound
Ultrasonography of the liver and bile ducts is warranted in infants with laboratory or clinical signs of cholestatic disease.
References